For treatment of: Cardiomagnyl,angina, prevention of cardiovascular diseases, prevention of atherothrombotic events, prevention of major cardiovascular complications, prevention of thromboembolism.Cardiomagnyl
- For the treatment of internal organs: circulatory system, blood vessels.
- Appointment: angina, prevention of cardiovascular diseases, prevention of atherothrombotic events, prevention of major cardiovascular complications, prevention of thromboembolism.
- Indications for use:
Primary prevention of cardiovascular diseases such as thrombosis and acute heart failure in the presence of risk factors (for example, diabetes, hyperlipidemia, hypertension, obesity, Smoking, old age). Prevention of recurrent myocardial infarction and blood vessel thrombosis.
Prevention of thromboembolism after surgical interventions on the vessels (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty). Unstable angina.
Hypersensitivity to ASA, auxiliary substances of the drug and other NSAIDs, brain hemorrhage; tendency to bleeding (vitamin K deficiency, thrombocytopenia, hemorrhagic diathesis); bronchial asthma induced by salicylates and NSAIDs; erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase); gastrointestinal bleeding; severe renal failure (creatinine clearance less than 10 ml/min); pregnancy (I and III trimesters); lactation; glucose-6-phosphate dehydrogenase deficiency; simultaneous administration with methotrexate (more than 15 mg per week); children under 18 years of age.
Acetylsalicylic acid 75 mg /150 mg
Magnesium hydroxide 15,2 mg / mg for the 30.39
Corn starch 9.5 mg /19.0 mg
Microcrystalline cellulose 12.5 mg / 25.0 mg
Magnesium stearate 150 mcg/ 305 mcg
Potato starch 2.0 mg / 4.0 mg
Hypromellose (methyl-hydroxypropyl-cellulose 15) 460 mcg /1.2 mg
Propylene glycol 90 mcg / 240 mcg
Talc 280 mcg / 720 mcg.
- Manufacturer: Takeda